J. Beuth
Impact in
- Biotechnology top 2%
- Transgenic Plants and Applications
- Immunology top 5%
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Glycosylation and Glycoproteins Research 9
- Immunology 37
- Toxin Mechanisms and Immunotoxins 24
- Immune Response and Inflammation 7
- Co-authors
- G. Pulverer (50 shared papers)H.L. Ko (36 shared papers)G. Uhlenbruck (15 shared papers)Jörg Michael Schierholz (9 shared papers)Berthold Schneider (5 shared papers)K. Oette (5 shared papers)Hans‐Joachim Gabius (3 shared papers)B Schneider (4 shared papers)
- Journals
- Medical Microbiology and Immunology (3 papers)Journal of Cancer Research and Clinical Oncology (3 papers)Infection (2 papers)Vaccine (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- GermanyPolandUnited Kingdom
In The Last Decade
J. Beuth
105 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 119
- Biotechnology 313
- Immunology 647
- Complementary and alternative medicine 241
- Microbiology 99
- Molecular Biology 699
Countries citing papers authored by J. Beuth
This map shows the geographic impact of J. Beuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Beuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Beuth more than expected).
Fields of papers citing papers by J. Beuth
This network shows the impact of papers produced by J. Beuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Beuth. The network helps show where J. Beuth may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Beuth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. | 2004 | 118 |
| 2 | Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany. | 2012 | 114 |
| 3 | Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe. | 2000 | 74 |
| 4 | 1992 | 72 | |
| 5 | 1997 | 63 | |
| 6 | 2001 | 55 | |
| 7 | 1987 | 54 | |
| 8 | 1995 | 53 | |
| 9 | Safety and efficacy of local administration of contractubex to hypertrophic scars in comparison to corticosteroid treatment. Results of a multicenter, comparative epidemiological cohort study in Germany. | 2006 | 51 |
| 10 | Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study. | 2004 | 48 |
| 11 | Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems. | 1991 | 48 |
| 12 | 2004 | 45 | |
| 13 | 2008 | 39 | |
| 14 | 2000 | 38 | |
| 15 | Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled multicenter comparative epidemiological cohort study. | 2008 | 30 |
| 16 | 1990 | 28 | |
| 17 | 2003 | 27 | |
| 18 | 1986 | 27 | |
| 19 | [Comparative studies on the immunoactive action of galactoside-specific mistletoe lectin. Pure substance compared to the standardized extract]. | 1993 | 26 |
| 20 | 1988 | 23 |
About J. Beuth
J. Beuth is a scholar working on Molecular Biology, Immunology, Biotechnology, Microbiology and Complementary and alternative medicine, having authored 112 papers that have together received 1.8k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (24 papers), Transgenic Plants and Applications (18 papers), Cancer Research and Treatments (14 papers), Antimicrobial Peptides and Activities (12 papers), Complementary and Alternative Medicine Studies (10 papers), Glycosylation and Glycoproteins Research (9 papers), Plant Parasitism and Resistance (8 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Biotechnology (313 citations), Immunology (647 citations), Complementary and alternative medicine (241 citations), Microbiology (99 citations) and Molecular Biology (699 citations). J. Beuth has collaborated with scholars based in Germany, Poland and United Kingdom. Frequent co-authors include G. Pulverer, H.L. Ko, G. Uhlenbruck, Jörg Michael Schierholz, Berthold Schneider, K. Oette, Hans‐Joachim Gabius, B Schneider, W. Roszkowski and Leo Auerbach. Their work appears in journals such as Medical Microbiology and Immunology, Journal of Cancer Research and Clinical Oncology, Infection, Vaccine and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.